| Type | Description |
|---|---|
| Definition | COX2 |
| Date | Results | Publications |
|---|---|---|
| 2020-11-21 13:31:00 | Inhibition of cyclooxygenase-1 by nonsteroidal anti-inflammatory drugs demethylates MeR2 enhancer and promotes Mbnl1 transcription in myogenic cells. | 32054946 |
| 2020-05-02 10:52:00 | CD90 depletion data demonstrated that local COX-2 overexpression targeted CD90(+) mSSCs to accelerate fracture repair. In conclusion, CD90(+) mSSCs are promising targets for the acceleration of bone repair. | 31392271 |
| 2020-01-11 12:14:00 | Selective disruption of COX-2 in adipose tissues failed detectably to impact systemic prostaglandin biosynthesis. | 30044978 |
| 2019-12-14 11:47:00 | long intergenic non-coding RNAs-Cox2 functions through an enhancer RNA mechanism to regulate Ptgs2. | 30404006 |
| 2019-04-27 11:11:00 | COX-2 inhibition normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 xenograft tumors in nude mice. | 28855534 |
| Type | IDs |
|---|---|
| Gene |
UniProtKB-ID:
A3E4B0_MOUSE
UniprotKB:
A3E4B0
UniParc:
UPI0000F1C8D5
EMBL:
EF108343,
DQ874614
|
| Nucleutide sequences |
EMBL-CDS:
ABH09672.1,
ABK79265.1
|
| Protein sequencees |
RefSeq:
YP_001686701.1
|
| Others |
UniRef100:
UniRef100_A3E4B0
UniRef90:
UniRef90_P00406
UniRef50:
UniRef50_P00403
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员